Overview
A monoclonal antibody is an immunoglobulin produced by a single clone of B cells, so that all molecules are identical and recognize a single epitope on a target antigen with defined specificity and affinity. Originally generated by hybridoma technology fusing antibody-producing cells with immortalized myeloma cells, monoclonal antibodies are now also derived by recombinant methods including phage display and single-chain variable fragment (scFv) engineering, and are produced as chimeric, humanized, or fully human formats to reduce immunogenicity. Their precise targeting makes them indispensable as research and diagnostic reagents and as therapeutics in oncology, autoimmunity, inflammation, and infectious disease, acting through neutralization, immune-cell recruitment, or blockade of signaling and immune-checkpoint pathways. Engineered derivatives include bispecific antibodies and antibody-based receptor probes. Research relevant to this area examines isolation of a human scFv antibody recognizing a serotonin-receptor heteromer, neutralizing antibodies in convalescent immune plasma against SARS-CoV-2, immunodetection of cellular markers in tumor aggressiveness, checkpoint blockade of the programmed cell death protein-1 pathway in melanoma, proteomic responses to targeted antibody therapy, and laboratory tests used in immune thrombocytopenia. This peer-reviewed literature reflects the generation, engineering, and therapeutic and diagnostic application of monoclonal antibodies across biomedical research, situating antibody technology within the broader study of immunology and targeted therapy.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Isolation of Human Monoclonal scfv Antibody Specifically Recognizing the D2-5-Ht1a Heteromer.
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
Cytoplasmic Retention of CDC6 Induces Premature Senescence in Immortalized Cells and Suppresses Tumor Formation in Mice
Relationship Between the Immunodetection of Alpha-Smooth Muscle Actin and the Aggressiveness of Mammary Papillar Tumors in Female Dog
Developing Cellular & Molecular Biomarkers for Anti-Inflammatory Activities of Probiotic Bacteria in Fermented Foods
Laboratory Tests Used in the Diagnosis of Immune Thrombocytopenia and General Treatment Approaches
Evolution of the Solid Human Tumor Cells Properties in Various Experimental Systems in Vitro
Determination of the Proteomic Response to Lapatinib Treatment using a Comprehensive and Reproducible Ion-Current-Based Proteomics Strategy
Tumor Growth Dynamics: Dietary Fish Oil Induced Inhibition of Human Breast Carcinoma Growth, A Phenomenon of Reduced Cellular DNA Synthesis or Increased Cell Loss?
Blockade of Programmed Cell Death Protein-1 Pathway for the Treatment of Melanoma
How this research is being cited
The 12 articles above have been cited 53 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Bioinformatics
-
2024 · Experimental Dermatology
-
2024 · Experimental Dermatology
-
2024 · WIREs Mechanisms of Disease
-
2023 · Biosensors and Bioelectronics
-
2023 · International Immunopharmacology
-
2023 · WIREs Mechanisms of Disease
-
2023 · International Journal of Pharmaceutical Sciences Review and Research
A sample of recent works citing this journal's research on Monoclonal Antibody, linking to each citing work.